Marc C.

Marc C. has a diverse professional background in the healthcare industry. Marc began their career in 2014 as the Deputy Director at Transplant Biomedicals. In 2018, they moved to the Germans Trias i Pujol Research Institute (IGTP) as the Head of Innovation and Business Development, where they were responsible for identifying, evaluating and prioritizing the ideas, inventions and research results of the Can Ruti Campus researchers. In 2020, they co-founded Kintsugi Therapeutics, where they currently serve as the COO.

Marc C. obtained a Cambridge Certificate in Proficiency English from the University of Cambridge in May 2009. Marc also obtained a CTY Science course in Astrophysics and Cosmology from the Center For Talented Youth (Johns Hopkins University) in July 2008. Marc completed a B.Sc. in Biotechnology from Universitat de Girona between 2010 and 2014. Marc then went on to obtain a Master in Business Management in Biomedicine and Health Biotechnology from Universitat de Barcelona between 2014 and 2015.